How the Tech Behind a COVID-19 Vaccine is Helping Save Bees:

GreenLight featured in Time magazine this week - explaining our trials of RNA to protect honeybees from the varroa destructor mite.

time.com/6291153/covid-…

GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction

greenlightbiosciences.com/greenlight-bio…

GreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress

greenlightbiosciences.com/greenlight-bio…

Our partnership with Julia Bally and QUT could help provide a more environmentally-friendly solution to the fall armyworm.

greenlightbiosciences.com/greenlight-bio…

Our potato beetle solution Calantha was the subject of a study in the Journal of Economic Entomology this year:

entomologytoday.org/2023/04/06/rna…

GreenLight research continues to be featured in leading journals. We will update this list of 2023 publications from GreenLight over the course of the year:

greenlightbiosciences.com/2023-greenligh…

GreenLight Biosciences Releases Inaugural Sustainability Report

greenlightbiosciences.com/greenlight-bio…

GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results

greenlightbiosciences.com/greenlight-bio…

Our first RNA solution, to protect against the Colorado Potato Beetle, covered by Thomas Skernivitz of Growing Produce here:

growingproduce.com/vegetables/pot…

GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Human Health R&D Day

greenlightbiosciences.com/greenlight-bio…

GreenLight Biosciences to Host R&D Day Series on Plant and Human Health Development Strategy.

greenlightbiosciences.com/glrdrelease/

Our agreement with EpiVax to develop personalized cancer vaccines was covered recently by Mary C. Serreze of Providence Business First.

bizjournals.com/boston/news/20…

GreenLight CEO Andrey Zarur notes the importance of bringing RNA vaccine trials and, eventually, manufacturing, to Africa.

Interview by CNBC Africa

cnbcafrica.com/media/63198816…

GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate

greenlightbiosciences.com/greenlight-bio…

Our work to protect bees from the Varroa destructor mite is mentioned in this article from Coco Liu of Bloomberg.

bloomberglinea.com/english/a-biot…

Thank you to everybody for your positive feedback on our CEO's vision for using RNA to feed the world and keep it healthy, presented at the Abu Dhabi Sustainability Week today.

Andrey Zarur, GreenLight CEO, has been sharing our vision for supporting sustainability through feeding the world and keeping it healthy at Abu Dhabi Sustainability Week today. Further details can be found at:

abudhabisustainabilityweek.com/ADSW/ADSW-Even…